Delivery Order SPE2DB25D3012-SPE2DB25FWZFU
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $10,374.00 to AmerisourceBergen Drug Corp for the supply of Doxycycline Hyclate 100 mg tablets (300 count) on August 21, 2025, with an ultimate completion date of August 22, 2025. This competitively awarded contract utilizes firm fixed pricing with no set-aside designation. The pharmaceutical product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where the company maintains its corporate office. This...
- The Defense Logistics Agency awarded a delivery order valued at $4,884.22 to AmerisourceBergen Drug Corp for the supply of Doxycycline Hyclate 100 mg capsules (500-count units). This competitively awarded, firm fixed-price delivery order was issued on August 22, 2025, with an ultimate completion date of August 25, 2025. The contract carries no set-aside designation, and the place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a $2,583.00 delivery order to AmerisourceBergen Drug Corp for the supply of 1,000 tablets of Doxycycline Hyclate 100 mg, with an ultimate completion date of August 26, 2025. This is a firm fixed price delivery order with no set-aside designation, meaning it was competitively awarded. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate office. Doxycycline Hyclate is a widely-used...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 6, 2025, for the supply of Doxycycline Hyclate 100 mg tablets in quantities of 1,000 units, valued at $2,151.96. This is a firm fixed price delivery order with an ultimate completion date of June 9, 2025, and represents a non-competitive set-aside contract. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 10, 2025, for the supply of Doxycycline Hyclate 100 mg tablets in a quantity of 1,000 units, valued at $1,565.14. This contract utilizes firm fixed pricing and carries an ultimate completion date of July 11, 2025. The award represents a non-set-aside, competitively awarded delivery order with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Doxycycline Hyclate 100 mg capsules (500-count) with a ceiling value of $1,538.36. This firm fixed-price contract, which utilizes no set-aside designation, is scheduled for completion by August 8, 2025, with performance at the vendor's Conshohocken, Pennsylvania facility. The delivery order represents a continuation of AmerisourceBergen's extensive pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $1,126.63 to AmerisourceBergen Drug Corp for the supply of Doxycycline Hyclate 100 mg tablets in quantities of 1,000 units. This contract, issued on May 19, 2025, with an ultimate completion date of May 20, 2025, represents a firm fixed-price delivery order with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award falls under the company's...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for 500 tablets of Doxycycline Hyclate 100 mg, valued at $1,121.97, with an ultimate completion date of August 6, 2025. This competitively awarded, firm fixed-price delivery order was issued on August 5, 2025, with no set-aside designation. The product will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Doxycycline IR-DR 40 mg capsules (30-count) with a contract value of $3,077.22. This is a firm fixed-price delivery order with an ultimate completion date of August 27, 2025, and no set-aside designation was utilized. The order will be performed in Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate headquarters. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Doxycycline Monohydrate 100 mg capsules (250-count units) valued at $1,571.53 with a firm fixed price structure. The order, issued on September 24, 2025, represents a non-competitive set-aside award and is scheduled for completion by September 25, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this pharmaceutical supply delivery, which supports...
- SPE2DB25D3012Indefinite Delivery Contract
- SPE2DB25D3012-SPE2DB25FWZFUDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,000.28 to AmerisourceBergen Drug Corp for Doxycycline Hyclate 50 mg capsules (500-count supply) on August 15, 2025, with an ultimate completion date of August 18, 2025. This competitively awarded, non-set-aside contract employs firm fixed-price pricing and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This delivery order represents a routine pharmaceutical supply transaction supporting the company's role as a major federal medical supply vendor. AmerisourceBergen Drug Corp maintains an extensive portfolio of federal contracts with the Defense Logistics Agency and its Medical Supply Chain, supplying pharmaceuticals and medical commodities to military healthcare systems, the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities. The Doxycycline Hyclate delivery exemplifies the company's capability to fulfill federal medical procurement requirements across multiple therapeutic domains, including antibiotics and other essential medications critical to military and veteran healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 8/15/25 |